Company / Interest Expense
Pacira BioSciences, Inc. Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$17.4M
FY2025
5-year range
$16.6M / $40.0M
FY2021-FY2025
Trend
+5.3%
vs FY2024
Sector context
#19 of 44
Health Care
What the data says
At $17M, Pacira BioSciences, Inc.'s interest expense ranks #26 of 44 in the Health Care sector. Interest Expense returned to growth in FY2025 after 2 years of decline, reaching $17M.
Based on SEC 10-K filings.
$17M in FY2025 with a 5-year CAGR of -4.5%.
Improved from $20M to $17M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -24.1%
- 5-Year CAGR
- -4.5%
- 10-Year CAGR
- -
Sector benchmark
#26 of 44 in Health CareTop 57% of 44This company $17.4M Sector average $291.0M
▼
-94.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -4.5%, indicating a declining trend.
- In FY2025, interest expense increased 5.3% year-over-year.
- Ranks #19 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.4M | +5.3% |
| FY2024 | $16.6M | -18.4% |
| FY2023 | $20.3M | -49.2% |
| FY2022 | $40.0M | +69.2% |
| FY2021 | $23.6M | +7.6% |
| FY2020 | $21.9M | +21.6% |
| FY2019 | $18.0M | +155.6% |
| FY2018 | $7.1M | -8.6% |
| FY2017 | $7.7M | +9.4% |
| FY2016 | $7.1M | -8.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026